Asthma exacerbations: A molecular dichotomy between antiviral and pro-inflammatory responses revealed

EMBO Molecular Medicine

Volumn 4, Issue 12, 2012, Pages 1231-1233

  Andreakos, Evangelos ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Allergic inflammation; Asthma exacerbations; P65 NF B; Rhinovirus; Type I interferon

Indexed keywords

CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL2 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; SYNAPTOTAGMIN I;

ADAPTIVE IMMUNITY; ASTHMA; BRONCHOSPASM; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; GOBLET CELL; HUMAN; IMMUNE RESPONSE; INFECTION SENSITIVITY; INFLUENZA; INHIBITION KINETICS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; NATURAL KILLER CELL; NOTE; PARAINFLUENZA VIRUS INFECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFECTION; RHINOVIRUS INFECTION; TH2 CELL; UPREGULATION; VIRAL CLEARANCE; VIRUS LOAD; WHEEZING;

ANIMALS; FEMALE; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; NF-KAPPA B; PHOSPHOPROTEINS; RHINOVIRUS;

EID: 84872421909     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201202032     Document Type: Note

References (9)

1. Andreakos E, Sacre SM, Smith C, Lundberg A, Kiriakidis S, Stonehouse T, Monaco C, Feldmann M, Foxwell BM (2004) Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 103: 2229-2237.
2. Apostolou E, Thanos D (2008) Virus Infection Induces NF-kappaB-dependent interchromosomal associations mediating monoallelic IFN-beta gene expression. Cell 134: 85-96.
3. Balachandran S, Beg AA (2011) Defining emerging roles for NF-kappaB in antivirus responses: revisiting the interferon-beta enhanceosome paradigm. PLoS Pathog 7: e1002165.
4. Bartlett NW, Walton RP, Edwards MR, Aniscenko J, Caramori G, Zhu J, Glanville N, Choy KJ, Jourdan P, Burnet J, et al (2008) Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med 14: 199-204.
5. Bartlett NW, Slater L, Glanville N, Haas JJ, Caramori G, Casolari P, Clarke DL, Message SD, Aniscenko J, Kebadze T, et al (2012) Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus. EMBO Mol Med DOI: 10.1002/emmm.201201650.
6. Busse WW, Lemanske RF, Jr, Gern JE (2010) Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 376: 826-834.
7. Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE (2012) Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36: 166-174.
8. Jackson DJ, Sykes A, Mallia P, Johnston SL (2011) Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 128: 1165-1174.
9. Koltsida O, Hausding M, Stavropoulos A, Koch S, Tzelepis G, Ubel C, Kotenko SV, Sideras P, Lehr HA, Tepe M, et al (2011) IL-28A (IFN-lambda2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol Med 3: 348-361.